Transcription
Monday, October 1, 2018Registration OpenRoom: Harborside Registration Desk11:00 am – 8:30 pmInspectors Training WorkshopRoom: Harborside D/E1:00 pm – 4:30 pmPre-Meeting Symposium: There is No ‘I’ in HLA: Skills forLeadership and Team BuildingRoom: Harborside A/BModerator: John Hart, MBA, Perineologic, Cumberland, MD, USA1:00 pm – 3:00 pmLeadership and Team BuildingChristopher Myers, PhDJohns Hopkins UniversityBaltimore, MD, USA3:00 pm – 3:30 pmCoffee Break3:30 pm – 5:00 pmHLA Leader Discussion PanelWalter Herczyk, BS, MT (ASCP),CHS(ABHI)Gift of Life MichiganAnn Arbor, MI, USAOpening Session: “Shark Tank” – Virtual Crossmatch: Bloodin the WaterRoom: Harborside BallroomSharks: Robert Cole, MD, FHFSA, Emory University, Atlanta, GA,USA, Sam Ho, PhD, D(ABHI), Gift of Life Michigan, Ann Arbor, MI,USA, Robert Montgomery, MD, D.Phil, FACS, NYU LangoneHealth, New York, NY, USA, Kathryn Tinckam, MD, MMSc,FRCPC, FAST, University Health Network and University ofToronto, Toronto, ON, CAN6:00 pm – 6:10 pmPro Virtual CrossmatchPaul Warner, PhD, D(ABHI)Bloodworks NorthwestSeattle, WA, USA6:10 pm – 6:20 pmPro Physical CrossmatchAnnette Jackson, PhD, D(ABHI)Johns Hopkins UniversityBaltimore, MD, USA6:20 pm – 6:50 pmShark/Audience DiscussionRobert Cole, MD, FHFSAEmory UniversityAtlanta, GA, USASam Ho, PhD, D(ABHI)Gift of Life MichiganAnn Arbor, MI, USARobert Montgomery, MD, D.Phil,FACSNYU Langone HealthNew York, NY, USACathi Murphey, PhDSouthwest Immunodiagnostics, Inc.San Antonio, TX, USALori Osowski, MS, CHS(ABHI)University of Maryland Medical CenterBaltimore, MD, USAKathryn Tinckam, MD, MMSc, FRCPC,FASTUniversity Health Network, Universityof TorontoToronto, ON, CANFirst Time Attendees & New Members Reception*Room: Waterview Ballroom5:00 pm – 6:00 pm*By invitation onlyKathryn Tinckam, MD, MMSc,FRCPC, FASTUniversity Health Network andUniversity of TorontoToronto, ON, CAN6:50 pm – 7:00 pmFinal Shark DebateOpening Reception with Exhibits OpenRoom: Grand Ballroom7:00 pm – 9:00 pm
Tuesday, October 2, 201810:45 am – 11:30 amRegistration OpenRoom: Harborside Registration Desk7:00 am – 7:00 pmThe Distinguished Service Award, The OutstandingTechnologist Award and Rising Star AwardRoom: Harborside Ballroom8:00 am – 8:30 amModerators: Patricia Campbell, MBChB, FRCPC, University ofAlberta Hospital, Edmonton, AB, CAN and John Schmitz, PhD,D(ABHI, ABMLI), UNC at Chapel Hill, Chapel Hill, NC, USADistinguishedService:John A. Gerlach, PhD, D(ABHI)Michigan State UniversityEast Lansing, MI, USAOutstandingTechnologist:Anne Halpin, MScUniversity of AlbertaEdmonton, AB, CANRising StarAward:Danielle Christian, BSc, MLTCalgary Cancer CentreEdmonton, AB, CANKeynote AddressRoom: Harborside Ballroom8:30 am – 9:30 amThe Evolution of TransplantationAllan D. Kirk, MD, PhDDuke University and Duke University Health SystemDurham, NC, USACoffee Break, Exhibit Hall OpenRoom: Grand Ballroom9:30 am – 10:00 amSymposium I: Novel Desensitization StrategiesRoom: Harborside BallroomModerators: Myra Coppage, PhD, HCLD (ABB), University ofRochester, Rochester, NY, USA and Amy Hahn, PhD,D(ABHI), Albany Medical College, Albany, NY, USA10:00 am – 10:45 amStreptococcal IgG DegradingEnzyme IdeS: Is it a GameChangerRobert Montgomery, MD, D.Phil,FACSNYU Langone HealthNew York, NY, USAShortening the Half-Life of IgGwith Anti-Neonatal Fc ReceptorAntibodyWilliam Baldwin, MD, PhD,Lerner Research Institute –Cleveland ClinicCleveland, OH, USAHot Topic: CRISPR Cas9Room: Harborside BallroomModerator: John Gerlach, PhD, D(ABHI), Michigan StateUniversity, East Lansing, MI, USA11:30 am – 12:20 pmCRISPR Cas9John Doench, PHDBroad InstituteCambridge, MA, USAUser Group Meetings (Ticketed Sessions)12:30 pm – 2:20 pmSteering the Patient Journey: Improved OutcomesThrough a Spectrum of Pre- and Post-TransplantDiagnostic SolutionsRoom: Harborside A/BSponsored by ImmucorAdvancing the Pre-to-Post Transplant ContinuumRoom: Harborside CSponsored by CareDx, Inc.Advancements in HLA GenotypingRoom: Harborside D/ESponsored by One Lambda Inc., a Thermo FisherScientific BrandScholar Award Abstract SessionRoom: Harborside A/BModerators: Sallyanne Fossey, PhD, D(ABHI), DCI Inc.,Nashville, TN, USA and John Lunz, Gift of Hope Organ &Tissue Donor Network, Itasca, IL, USA2:30 pm – 2:52 pmINVISIBLE ORGANS MADE BYGENETIC ENGINEERING TOTURN OFF MHC PRIOR TOALLOGENEICTRANSPLANTATION PREVENT APRO-INFLAMMATORYCYTOKINE RESPONSE IN THERECIPIENT (Abstract #OR1)Rainer Blasczyk, MDHannover Medical School, Instituteof Transfusion MedicineHannover, Germany
2:52 pm – 3:14 pm3:14 pm – 3:36 pm3:36 pm – 3:58 pmLIGATION OF HLA CLASS IIMOLECULES PROMOTESENDOTHELIAL CELLPERMEABILITY THROUGHACTIVATED SRC AND ERKSIGNALS (Abstract #OR2)Fang Li, PhDUCLA Immunogenetics CenterLos Angeles, CA, USADEVELOPMENT OF HLA DENOVO DONOR SPECIFICANTIBODY IS ASSOCIATEDWITH PREFORMED NON-HLAAUTOANTIBODIES AND LUNGTRANSPLANTATION REJECTION(Abstract #OR3)Aiwen Zhang, PhD, D(ABHI)Allogen Laboratories/ClevelandClinicsCleveland, OH, USAHIGH RESOLUTION HAPLOTYPEANALYSES OF CLASSICAL HLAGENES IN FAMILIES WITHMULTIPLE SCLEROSIS (Abstract#OR4)Kazutoyo Osoegawa, PhD,CHT(ABHI)Stanford Blood CenterPalo Alto, CA, USAWorkshop I: UNOS IT WorkshopRoom: Harborside D/EModerators: Michael Gautreaux, PhD, D(ABHI), Wake ForestSchool of Medicine, Winston-Salem, NC, USA and JohnSchmitz, PhD, D(ABHI, ABMLI), UNC at Chapel Hill, ChapelHill, NC, USA2:30 pm – 3:00 pmUNOS ITAlex Tulchinsky and Dean WilsonUnited Network for Organ SharingRichmond, VA, USA3:00 pm – 3:15 pmHLA Data Systems/mTildaCollin Brack, MBA, FHIMSSHLA Data SystemsHouston, TX, USA3:15 pm – 3:30 pmSystemLink/HistotracScot TownshendSystemLink Inc.Reston, VA, USA3:30 pm – 4:00 pmInteraction and QuestionsCoffee Break with ExhibitsRoom: Grand Ballroom4:00 pm – 4:30 pmAbstract Session I: Solid Organ Pre/PostTransplant Testing IRoom: Harborside A/BModerators: TBD4:30 pm – 4:42 pmDONOR SPECIFIC ANTIBODY(DSA) ASSESSMENTS USINGHLA P GROUPS: THE DEVIL IS INTHE DETAILS (Abstract #OR5)June Jones, Annette M. Jackson,Donna P. Lucas, Maria Bettinotti.Baltimore, MD.4:42 pm – 4:54 pmSUCCESSFUL DECEASEDDONOR KIDNEYTRANSPLANTATION OF HIGHLYSENSITIZED CANDIDATESACROSS POSITIVE CROSSMATCH AND STRONG DONORSPECIFIC HLA-DP ANTIBODIESWITHOUT DESENSITIZATION(Abstract #OR6)Raja Rajalingam, David Gae, ZoltanG. Laszik, Kelly J. Cunniffe, JohnRoberts. San Francisco, CA.4:54 pm – 5:06 pmHLA EXPRESSION ON T AND BCELLS - COMPARISONS TOINFLAMED ENDOTHELIUM(Abstract #OR7)Luis Hidalgo. Edmonton, AB,Canada.5:06 pm – 5:18 pmA NOVEL REACTIVITY PATTERNWITH LABSCREENTM CLASS ISINGLE ANTIGEN BEADS ANDITS PREVALENCE AMONG SLEPATIENTS (Abstract #OR8)Christina L. Dean, Robert A. Bray,Howard M. Gebel, Harold C.Sullivan. Atlanta, GA.
5:18 pm – 5:30 pmHLA-C TARGETEDCROSSMATCHES ARE SERUMDEPENDENT, ANDTRANSPLANTS WITH STRONGPRE-FORMED DONOR-SPECIFICHLA-C ANTIBODIES BUTNEGATIVE CROSSMATCHES DONOT EXPERIENCE ANTIBODYMEDIATED REJECTION (Abstract#OR9)Kelly Cunniffe, Ahrles Cajulao, JackLai, Raja Rajalingam. SanFrancisco, CA.5:30 pm – 5:42 pmDATA-DRIVENMODELING OFFLOW CYTOMETRICCROSSMATCH: ENHANCEDVIRTUAL CROSSMATCHING(Abstract #OR10)Eric T. Weimer, Katherine A.Newhall. Chapel Hill, NC.5:42 pm – 5:54 pmCHARACTERISTICS OFTRANSPLANT CANDIDATESWITH CPRA 99.95% LIKELY TOBE ALLOCATED ORGANS FROMDECEASED DONORS.(Abstract #OR11)Ronald Parsons, Hannah Decker,Rachel Patzer, Shalini Bumb,Harold C. Sullivan, Robert A. Bray,Howard M. Gebel. Atlanta, GA.Abstract Session II: Immunotherapy/Rejection & PostTransplant TestingRoom: Harborside CModerators: Robert Bray, PhD, D(ABHI), HCLD/CC(ABB),Emory University, Atlanta, GA, USA and Sam Ho, PhD,D(ABHI), Gift of Life Michigan, Ann Arbor, MI, USA4:30 pm – 4:42 pmMONITORING CD8 DONORLYMPHOCYTE CHIMERISM IS ACRITICAL INDICATOR FORDIAGNOSING AND TREATINGACUTE GRAFT VS. HOSTDISEASE FOLLOWING LIVERTRANSPLANTATION (Abstract#OR12)Aiwen Zhang, Bijan Eghtesad,Yuchu Sun, Jessica Bollinger,Christina Lindenmeyer, RaymondJurcago, Medhat Z. Askar, JohnFung. Cleveland, OH.4:42 pm – 4:54 pmIDENTIFICATION ANDCHARACTERIZATION OF APANEL OF NON-HLAANTIBODIES IN KIDNEYALLOGRAFT REJECTION(Abstract #OR13)Carrie L. Butler, Michelle J. Hickey,David W. Gjertson, Meghan Pearl,Maura Rossetti, J. Michael Cecka,Fadi Kandarian, Gemalene Sunga,Qiuheng Zhang, Bryan L. Ray,Elaine F. Reed. Los Angeles, CA.4:54 pm – 5:06 pmRELEVANCE OF MICA-129DIMORPHISM IN LIVE DONORRENAL TRANSPLANTATION(Abstract #OR14)Ajay K. Baranwal, Deepali K. Bhat,Wahid Boukouaci, Ryad Tamouza,Dominique Charron, Sanjay K.Agarwal, Narinder K. Mehra. NewDelhi, Delhi, India.5:06 pm – 5:18 pmPROGRESSIVE CHRONICTISSUE INJURY WITHOUTACTIVE PATHOLOGICALCHANGES IS THEHISTOLOGICAL HALMARK OFDE NOVO CLASS II DSA(Abstract #OR15)Pouneh Dokouhaki, Elly Johnson,Qingyong Xu. Saskatoon, SK,Canada.5:18 pm – 5:30 pmHLA EPITOPE-MISMATCH MOREPRECISELY PREDICTS THEDEVELOPMENT OF DE NOVODONOR SPECIFIC ANTIBODYAND ACUTE CELLULARREJECTION AFTER LUNGTRANSPLANT (Abstract #OR16)Aiwen Zhang, Nathan Stopczynski,Dawn Thomas, Yuchu Sun, JohnMcMichael, Paul Kawczak, JeffreyAllen, Marie Budev, Robert A. Bray,Howard Gebel. Cleveland, OH.
5:30 pm – 5:42 pm5:42 pm – 5:54 pmEPITOPE LOAD DOES NOTPREDICT DEVELOPMENT OF DENOVO ANTIBODIES TO HLA INPATIENTS WITH BK VIRUSNEPHROPATHY(Abstract #OR17)Darshana Dadhania, Cindy Park,Vadim J. Jucaud, Matthew Everly,Rex Friedlander, Arvind K. Menon,Prabhakar Putheti, Vijay K.Sharma, Manikkam Suthanthiran.New York, NY.COMPOSITE IMPACT OF COLIGATION OF HLA-I AND HLA-IIANTIBODY-MEDIATEDACTIVATION OF HUMAN AORTICENDOTHELIAL CELLS(Abstract #OR18)Yi-Ping Jin, Elaine F. Reed. LosAngeles, CA.Workshop II: Do It Yourself: Be The Match’s ToolboxRoom: Harborside D/EModerators: Maria Bettinotti, PhD, D(ABHI), FACMG, JohnsHopkins University, Baltimore, MD, USA and MarceloFernandez-Vina, PhD, D(ABHI), Stanford University, Palo Alto,CA, USA4:30 pm – 6:00 PMJanelle Olson, PhD, CHTCNMDP/Be The MatchMinneapolis, MN, USAYung-Tsi Bolon, PhDCenter for International Blood andMarrow Transplant ResearchMinneapolis, MN, USAWednesday, October 3, 2018The Tulip Run: 5K Run/1 Mile WalkOffsite: Patterson Park6:30 am – 8:00 amRegistration OpenRoom: Harborside Registration Desk8:00 am – 6:00 pmScientific Award Presentation: Rose Payne AwardRoom: Harborside Ballroom8:30 am – 9:30 amModerator: Michael Gautreaux, PhD, D(ABHI), Wake ForestSchool of Medicine, Winston-Salem, NC, USAChanging the Dogmas in Histocompatibility andTransplantationThalachallour Mohanakumar, PhD, D(ABHI),HCLD/CC (ABB)Norton Thoracic Institute Research LaboratoryPhoenix, AZ, USACoffee Break, Exhibit Hall OpenRoom: Grand Ballroom9:30 am – 10:00 amSymposium II: HCT as Immunotherapy: Garnering thePower of Natural Killer CellsRoom: Harborside BallroomModerators: Maria Bettinotti, PhD, D(ABHI), FACMG, JohnsHopkins University, Baltimore, MD, USA and Mary Carrington,MS, PhD, Frederick National Laboratory for Cancer Research,Frederick, MD, USA10:00 am – 10:15 amIntroduction on NK – KIR-HLAMary Carrington, MS, PhDFrederick National Laboratory forCancer ResearchFrederick, MD, USA10:15 am – 10:45 amHCT Donor Selection: TheMinneapolis WaySarah Cooley, MD, MSUniversity of MinnesotaMinneapolis, MN, USA10:45 am – 11:30 amHCT Donor Selection: TheNew York WayKatherine Hsu, MD, PhDMemorial Sloan Kettering CancerCenterNew York, NY, USAPoster Reception with ExhibitsRoom: Grand Ballroom6:00 pm – 7:45 pmARB Inspectors & International Reception*Room: Waterview Ballroom7:00 pm – 9:00 pm*By invitation only
Hot Topic: The Challenges of Car-T TherapyRoom: Harborside BallroomModerators: Peter Lalli, PhD, D(ABHI), Carolinas PathologyGroup, Charlotte, NC, USA and Eric Weimer, PhD, UNC atChapel Hill, Chapel Hill, NC, USA11:30 am – 12:20 pm2:54 pm – 3:06 pmHLA-C DOWNREGULATION BYHIV ADAPTS TO HOST HLAGENOTYPE (Abstract #OR21)Richard Apps, Nathaniel Bachtel,Gisele Umviligihozo, SuzannePickering, Talia Mota, Hua Liang,Gregory Del Prete, PramitaChatterjee, Guinevere Lee, RasmiThomas, Mark Brockman, StuartNeil, Mary Carrington, BoscoBwana, David Bangsberg, JeffreyMartin, Esper Kallas, CamilaDonini, Natalia Cerqueira, UnaO’Doherty, Beatrice Hahn, BradJones, Zabrina Brumme, DouglasNixon. Washington DC.3:06 pm – 3:18 pmHLA-G REGULATORY ANDCODING REGION HAPLOTYPESIN PAPILLARY THYROIDCARCINOMA (Abstract #OR22)Bruna C. Bertol, GuilhermeDebortoli, Fabrício C. Dias, JéssicaN. Góes de Araújo, Nathalie L. DeFigueiredo-Feitosa, Vivian NogueiraSilbiger, Celso Teixeira MendesJunior, Erick C. Castelli, Léa M.Zanini Maciel, Eduardo A. Donadi.Ribeirão Preto, Brazil.3:18 pm – 3:30 pmHLA CLASS II GENESCORRELATE WITH PROTECTIVENEUTRALIZING ANTIBODYTITERS IN A DENGUE VACCINEEFFICACY TRIAL (Abstract#OR23)Aviva Geretz, Shida Shangguan,Chris Bryant, Philip Ehrenberg,Merlin Robb, Richard Jarman, AlainBouckenooghe, Nelson Michael,Danaya Chansinghakul, RasmiThomas. Silver Spring, MD.The Challenges of Car-T TherapyJoseph Fraietta, PhDUniversity of PennsylvaniaPhiladelphia, PA, USAUser Group Meetings12:30 pm – 2:20 pmBD Biosciences Lunch SymposiumRoom: Harborside A/BSponsored by BD BiosciencesImprovements in Transplant Diagnostics. What'snext? A Closer Look at Chimerism Monitoring andNGS HLA TypingRoom: Harborside CSponsored by GenDxManaging Antibody Mediated RejectionRoom: Harborside D/ESponsored by One Lambda Inc., a Thermo FisherScientific BrandAbstract Session III: Genetic Polymorphism &Anthropology DiseaseRoom: Harborside A/BModerators: Eric Weimer, PhD, UNC at Chapel Hill, ChapelHill, NC, USA and Carley Shaut, PhD, D(ABHI), Oregon Health& Science University, Portland, OR, USA2:30 pm – 2:42 pmINTEGRATE CRISPR/CAS9 FORPRECISE PROTEIN EXPRESSIONOF HLA-B*38:68Q (Abstract#OR19)Yuxin Yin, Elaine F. Reed, QiuhengZhang. Los Angeles, CA.2:42 pm – 2:54 pmINVESTIGATING THE MICRORNAPROFILE OF B CELL LINES FORTHEIR DIFFERENTIAL EFFECTON HAPLOTYPE SPECIFIC DPB1GENE EXPRESSION (Abstract#OR20)Mengkai Shieh, Dimitrios S. Monos.Philadelphia, PA.
3:30 pm – 3:42 pm3:42 pm – 3:54 pmHLA ALLELE AND HAPLOTYPEFREQUENCIESCHARACTERIZED USING NEXTGENERATION SEQUENCINGMETHODS IN UNRELATEDWORLD-WIDE POPULATIONS:SUMMARY FROM THE 17thINTERNATIONAL HLA ANDIMMUNOGENETICS WORKSHOP(Abstract #OR24)Lisa E. Creary, Chia-Jung Chang,Gonzalo Montero Martin, Kalyan C.Mallempati, Sridevi Gangavarapu,Kazutoyo Osoegawa, Tamara A.Vayntrub, Marcelo A. FernandezVina. Palo Alto, CA.THE HIGHLY POLYMORPHICHLA-DRA GENE: CONSERVEDAND DIVERSE REGIONS WITHINTHE HLA-DRA GENE IMPLYHAPLOTYPES OFDRA DRB3/4/5 DRB1 DQB1(Abstract #OR25)Benedict M. Matern, Timo I.Olieslagers, Laura de Rooij,Christien E. Voorter, MathijsGroeneweg, Marcel G. Tilanus.Maastricht, Netherlands.2:42 pm – 2:54 pmNOVEL NEXT GENERATIONSEQUENCING BASEDCHIMERISM ASSAY FORENGRAFTMENT MONITORING INHEMATOPOIETIC CELLTRANSPLANTATION (Abstract#OR27)Medhat Z. Askar, Amanda Willis,Jenifer D. Williams, Leah Pittmon,Shalini E. Pereira, Anajane G.Smith, Chulwoo Pyo, Wyatt Nelson,Daniel E. Geraghty. Dallas, TX.2:54 pm – 3:06 pmHAPLOIDENTICAL DONORS FORHEMATOPOIETIC CELLTRANSPLANTATION (HCT):CHANGING DEMOGRAPHICSAND THE ECONOMICS OFTYPING THIS POPULATION(Abstract #OR28)Suraya A. Berger, Nancy L.Delaney Rossiter, KevinChesterton, Annette M. Jackson,Maria Bettinotti.Baltimore, MD.3:06 pm – 3:18 pmHIGHER PERCENT RECIPIENTCHIMERISM IN BONE MARROWTHAN PERIPHERAL BLOOD ISRISK FOR RELAPSE (Abstract#OR29)Lorie H. Kumer, Jennifer Tyler,Carolyn Fisher, Heather Casey,Shin Mineishi, David Claxton,Witold Rybka, Seema Naik,Muhammad Khawaja, Hong Zheng,Hiroko Shike. Hershey, PA.3:18 pm – 3:30 pmHLA EXPRESSION ON CD34 STEM CELLS: IS A FLOWCYTOMETRIC CROSSMATCH AGOOD GATEKEEPER FORMISMATCHED HEMATOPOIETICCELL TRANSPLANTION?(Abstract #OR30)Maria P. Bettinotti, Donna P. Lucas,Gabriel Ghiaur, Annette M.Jackson, Douglas E. Gladstone.Baltimore, MD.Abstract Session IV: Bone Marrow, HSCT, ChimerismRoom: Harborside CModerator: Maria Bettinotti, PhD, D(ABHI), FACMG, JohnsHopkins University, Baltimore, MD, USA2:30 pm – 2:42 pmINVESTIGATING THE IMPACT OFPATIENT’S NON-SHARED HLA-CALLOTYPE EXPRESSIONLEVELS IN A 9/10 SINGLE HLA-CMISMATCHEDHEMATOPOIETICSTEM CELLTRANSPLANTATIONSETTINGUSING TWO DIFFERENT HLA-CEXPRESSION PROXY MODELS(Abstract #OR26)Chrysanthi Tsamadou, DanielFürst, Markus Rojewski, DietgerNiederwieser, Donald Bunjes,Christine Neuchel, MartinGramatzki, Renate Arnold, EvaWagner, Hermann Einsele, SixtenKörper,Hubert Schrezenmeier, JoannisMytilineos. Ulm, Germany.
3:30 pm – 3:42 pmCHARACTERIZATION OF THECCR5 DELTA 32 MUTATION BYRACE IN UNRELATED DONORSLISTED ON THE NATIONALMARROW DONOR PROGRAM’SBE THE MATCH REGISTRY(Abstract #OR31)Miranda Bauer, Cynthia VierraGreen, Elizabeth Beduhn, StephenR. Spellman, Jason Dehn.Minneapolis, MN.Workshop III: Uh Oh What Do I Do Now? Stories of HLA:The Good, The Bad and The UglyRoom: Harborside D/EModerator: Sharon Adams, MT(ASCP), CHS (ABHI), NationalInstitutes of Health, Bethesda, MD, USA and Paul Warner,PhD, D(ABHI), Bloodworks Northwest, Seattle, WA, USA2:30 pm – 4:00 pmPanelist DiscussionJana Osbey, CHS(ABHI)Houston Methodist HospitalHouston, TX, USADavid Partlow, MS, MBA, CHS, MTThe University of Texas MDAnderson Cancer CenterHouston, TX, USASandra Resto-Ruiz, PhD, HCLD/CCLifeLink TransplantationImmunology LaboratoryTampa, FL, USAPhillip Ruiz, MD, PhDUniversity of MiamiMiami, FL, USAWorkshop IV: ARB/QAS/PT UpdateRoom: LaurelModerators: Walter Herczyk, BS, MT(ASCP), CH (ABHI), Giftof Life Michigan, Ann Arbor, MI, USA and Taba Kheradmand,PhD, Midwest Transplant Network, Westwood, KS, USA2:30 pm – 3:00 pm3:00 pm – 3:30 pmAccreditation Review BoardUpdateZahra Kashi, PhDKashi Clinical LabsPortland, OR, USAProficiency Testing UpdateKelley Hitchman, MS, PhD,D(ABHI)UT Health San AntonioSan Antonio, TX, USA3:30 pm – 4:00 pmQuality Assurance StandardsUpdateMatthew Cusick, PhD, D(ABHI)Baylor College of MedicineHouston, TX, USACoffee Break with ExhibitsRoom: Grand Ballroom4:00 pm – 4:30 pmJoint Session: Directors’ & Technologists’ ForumRoom: Harborside A/B/C4:30 pm – 4:45 pmCall Options –Strategies/Structure4:45 pm – 5:00 pmCareer Options/Ladder WithinLabs5:00 pm – 5:15 pmDiscussionDirector’s Affairs ForumRoom: Harborside D/E5:15 pm – 6:00 pmTechnologists’ Affairs ForumRoom: Harborside A/B/C5:15 pm – 6:00 pmThursday, October 4, 2018Registration OpenRoom: Harborside Registration Desk7:30 am - 5:00 pmThe Paul I. Terasaki Clinical Science Award andDistinguished Scientist AwardRoom: Harborside Ballroom8:00 am – 9:30 amModerators: Michael Gautreaux, PhD, D(ABHI), Wake ForestSchool of Medicine, Winston-Salem, NC, USA and JohnSchmitz, PhD, D(ABHI, ABMLI), UNC at Chapel Hill, ChapelHill, NC, USAPaul I. Terasaki Jon A. Kobashigawa, MDAward:Cedars-Sinai Heart InstituteDistinguishedScientist:In the blink of an eye.My 40 years in HLAHoward M. Gebel, PhD, D(ABHI)Emory University School ofMedicineAtlanta, GA, USA
Coffee Break, Exhibit Hall OpenRoom: Grand Ballroom9:30 am – 10:00 amSymposium III: Non-Invasive Monitoring/Bio-MarkersRoom: Harborside BallroomModerators: Patricia Campbell, MBChB, FRCP (Edmin),FRCPC, University of Alberta Hospital, Edmonton, AB, CANand John Schmitz, PhD, D(ABHI, ABMLI), UNC at Chapel Hill,Chapel Hill, NC, USA10:00 am – 10:30 amOverview of Non-InvasiveBiomarkers of TransplantRejectionPeter Heeger, MDIcahn School of Medicine at MountSinaiNew York, NY, USA10:30 am – 11:00 amCell Free DNA and Role inMonitoring Graft FunctionHannah Valantine, MDNational Institutes of HealthBethesda, MD, USA11:00 am – 11:30 amExosomes and Their Role in theAlloimmune Response andPotential for Graft MonitoringAdrian Morelli, MD, PhDUniversity of PittsburghPittsburgh, PA, USAHot Topic: Analytics and Algorithms: Web-Based ClinicalDecision SupportRoom: Harborside BallroomModerator: Howard Gebel, PhD, D(ABHI), Emory University,Atlanta, GA, USA11:30 am – 12:20 pmBreak, Exhibits Closed2:20 pm – 2:30 pmAbstract Session V: New AssaysRoom: Harborside A/BModerator: Gerald Morris, MD, PhD, University of CaliforniaSan Diego, San Diego, CA, USA2:30 pm – 2:42 pmDIFFERENTIAL DETECTION OFGLYCOSYLATION
NYU Langone Health New York, NY, USA 10:45 am – 11:30 am Shortening the Half-Life of IgG with Anti-Neonatal Fc Receptor Antibody William Baldwin, MD, PhD, Lerner Research Institute – Cleveland Clinic Cleveland, OH, USA Hot Topic: CRISPR Cas9 Room: Harborside Ballroom Moderator:
